Cargando…

Transient Tumor-Fibroblast Interactions Increase Tumor Cell Malignancy by a TGF-β Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer

Carcinoma are complex societies of mutually interacting cells in which there is a progressive failure of normal homeostatic mechanisms, causing the parenchymal component to expand inappropriately and ultimately to disseminate to distant sites. When a cancer cell metastasizes, it first will be expose...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stuelten, Christina H., Busch, Johanna I., Tang, Binwu, Flanders, Kathleen C., Oshima, Akira, Sutton, Emily, Karpova, Tatiana S., Roberts, Anita B., Wakefield, Lalage M., Niederhuber, John E.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843748/ https://www.ncbi.nlm.nih.gov/pubmed/20352126 http://dx.doi.org/10.1371/journal.pone.0009832

Ejemplares similares

SDF-1α Mediates Wound-Promoted Tumor Growth in a Syngeneic Orthotopic Mouse Model of Breast Cancer
por: Stuelten, Christina H., et al.
Publicado: (2013)

Regulation of Tumor Immune Surveillance and Tumor Immune Subversion by TGF-β
por: Park, Hae-Young, et al.
Publicado: (2009)

A novel approach for the generation of genetically modified mammary epithelial cell cultures yields new insights into TGFβ signaling in the mammary gland
por: Kohn, Ethan A, et al.
Publicado: (2010)

How Little Is Too Much? – How Transient Tumor-Stromal Crosstalk Can Control Tumor Progression
por: Stuelten, Christina H.
Publicado: (2016)

Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium
por: Flanders, Kathleen C., et al.
Publicado: (2016)

Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
por: Chen, Xin, et al.
Publicado: (2014)

An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer
por: Sato, Misako, et al.
Publicado: (2014)

Brightfield Proximity Ligation Assay Reveals Both Canonical and Mixed Transforming Growth Factor-β/Bone Morphogenetic Protein Smad Signaling Complexes in Tissue Sections
por: Flanders, Kathleen C., et al.
Publicado: (2014)

Impact of Cancer-Associated Fibroblast on the Radiation-Response of Solid Xenograft Tumors
por: Steer, Alizée, et al.
Publicado: (2019)

Succession of transiently active tumor‐initiating cell clones in human pancreatic cancer xenografts
por: Ball, Claudia R, et al.
Publicado: (2017)

In Vivo Detection of Circulating Cancer-Associated Fibroblasts in Breast Tumor Mouse Xenograft: Impact of Tumor Stroma and Chemotherapy
por: Lu, Tao, et al.
Publicado: (2023)

Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
por: Maier, Armin, et al.
Publicado: (2015)

Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
por: Stuelten, Christina H., et al.
Publicado: (2021)

A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells
por: Tang, Binwu, et al.
Publicado: (2014)

TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts
por: Yamada, Chiaki, et al.
Publicado: (2016)

Transient perfusion in human melanoma xenografts.
por: Tufto, I., et al.
Publicado: (1995)

Transforming growth factors-β are not good biomarkers of chemopreventive efficacy in a preclinical breast cancer model system
por: Zujewski, JoAnne, et al.
Publicado: (2001)

The Impact of Tumor Nitric Oxide Production on VEGFA Expression and Tumor Growth in a Zebrafish Rat Glioma Xenograft Model
por: Yousfi, Nadhir, et al.
Publicado: (2015)

New mouse xenograft model modulated by tumor-associated fibroblasts for human multi-drug resistance in cancer
por: MA, YAN, et al.
Publicado: (2015)

In Vivo Evaluation of Fibroblast Growth Factor Receptor Inhibition in Mouse Xenograft Models of Gastrointestinal Stromal Tumor
por: Schöffski, Patrick, et al.
Publicado: (2022)

TGF-β signal rewiring sustains epithelial-mesenchymal transition of circulating tumor cells in prostate cancer xenograft hosts
por: Huang, Guangcun, et al.
Publicado: (2016)

Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model
por: Sato, Misako, et al.
Publicado: (2015)

TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
por: Tripathi, Veenu, et al.
Publicado: (2019)

Effective Chemoimmunotherapy with Anti-TGFβ Antibody and Cyclophosphamide in a Mouse Model of Breast Cancer
por: Chen, Xin, et al.
Publicado: (2014)

Cancer-associated fibroblasts stimulate primary tumor growth and metastatic spread in an orthotopic prostate cancer xenograft model
por: Linxweiler, Johannes, et al.
Publicado: (2020)

Applications of patient-derived tumor xenograft models and tumor organoids
por: Yoshida, Go J.
Publicado: (2020)

TGF-β1-mediated transition of resident fibroblasts to cancer-associated fibroblasts promotes cancer metastasis in gastrointestinal stromal tumor
por: Yoon, Hyunho, et al.
Publicado: (2021)

Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects
por: Luger, Dror, et al.
Publicado: (2013)

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()
por: Bondarenko, Gennadiy, et al.
Publicado: (2015)

Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)

Modeling Lung Carcinoids with Zebrafish Tumor Xenograft
por: Carra, Silvia, et al.
Publicado: (2022)

Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models
por: Wakefield, Lalage M, et al.
Publicado: (2000)

Delineating Genetic Alterations for Tumor Progression in the MCF10A Series of Breast Cancer Cell Lines
por: Kadota, Mitsutaka, et al.
Publicado: (2010)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts
por: Cybulska, Magdalena, et al.
Publicado: (2018)

The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
por: Fung, Andrea S, et al.
Publicado: (2015)

Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
por: Chen, Lei, et al.
Publicado: (2019)

Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
por: Rijensky, Nataly Mancette, et al.
Publicado: (2020)

Adenosine/TGFβ axis in regulation of mammary fibroblast functions
por: Vasiukov, Georgii, et al.
Publicado: (2021)

TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
por: Grauel, Angelo L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rsmurekftsg3t0h1nh36fd1efd